Navigation path

Pharmaceuticals - Community Register


Community register of veterinary medicinal products


Product information

Invented name: Porcilis ColiClos   
Auth. number : EU/2/12/141
Active substance : Escherichia coli and Clostridium perfringens vaccine
ATC: Anatomical main group: QI - Immunologicals
Therapeutic subgroup: QI09 - Immunologicals for suidae
Pharmacological subgroup: QI09A - Pig
Chemical subgroup: QI09AB - Inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia)
Chemical substance: QI09AB08 - escherichia + clostridium
(See WHO ATCvet Index)
Indication: For the passive immunisation of progeny by active immunisation of sows and gilts to reduce mortality and clinical signs during the first days of life, caused by those E. coli strains, which express the adhesins F4ab (K88ab), F4ac (K88ac), F5 (K99) or F6 (987P) and caused by C. perfringens type C.
Marketing Authorisation Holder: Intervet International B.V.
Wim de Körverstraat 35, 5831 AN Boxmeer, Nederland
EPAR and active package presentations

Package presentations

Information about presentations can be found in the website of the European Medicines Agency under the section "Product Information".
Likewise, presentations on which there has been a Commission decision are referred in the Summary of Product Characteristics (Annex I to the Commission Decision granting the marketing authorisation) which is available in the Community Register.

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
17/06/2012 Centralised - Authorisation EMEA/V/C/2011 (2012)4180 of 14/06/2012
4/04/2014 Centralised - Variation EMEA/V/C/2011/IA/2
Updated with Decision(2015)2919 of 24/04/2015
28/04/2015 Centralised - Yearly update (2015)2919 of 24/04/2015
8/07/2015 Centralised - Variation EMEA/V/C/2011/IB/4/G
Updated with Decision(2016)4962 of 25/07/2016
27/07/2016 Centralised - Yearly update (2016)4962 of 25/07/2016
31/03/2017 Centralised - Renewal EMEA/V/C/2011/R/6 (2017)2212 of 29/03/2017